Business Context and Reporting Period
This Form 8-K, dated February 23, 2026, reports the consummation of the initial public offering (IPO) by HCM IV Acquisition Corp., a Cayman Islands-based emerging growth company. The filing details the completion of the IPO on February 13, 2026, and a simultaneous private placement.
Key Financial Metrics
- IPO Proceeds: The Company sold 28,750,000 Units (including 3,750,000 from the full exercise of the over-allotment option) at $10.00 per Unit.
- Private Placement: The Company sold 4,666,667 Private Placement Warrants to the Sponsor and Cantor Fitzgerald & Co. at $1.50 per warrant, generating gross proceeds of $7,000,000.
- Trust Account: A total of $287,500,000 from the IPO proceeds was deposited into a U.S.-based trust account. This amount includes $13,687,500 of the underwriter's deferred discount.
- Capital Structure: Each Unit consists of one Class A ordinary share and one-quarter of one redeemable warrant. Whole warrants are exercisable for one Class A ordinary share at $11.50 per share.
Material Changes
The primary material change is the transition from a pre-IPO entity to a publicly traded company on The Nasdaq Stock Market LLC. The filing confirms the receipt of significant capital through the IPO and private placement, with an audited balance sheet as of February 13, 2026, reflecting these proceeds.
Outlook and Risks
The filing does not provide specific forward-looking guidance, management commentary on future targets, or a detailed discussion of risks beyond the standard disclosure of the IPO structure. The Company is designated as an emerging growth company. The filing notes the inclusion of an audited balance sheet as Exhibit 99.1.
Investor Verification Checklist
- Verify the final audited balance sheet (Exhibit 99.1) to confirm total cash and liabilities post-IPO.
- Confirm the exact terms of the deferred underwriting discount ($13,687,500) and its impact on net proceeds.
- Review the specific rights and redemption terms of the Class A ordinary shares and warrants.
- Check for any subsequent filings regarding the identification of a target business for the SPAC merger.